Institute for Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Sell |
901
-16
| -2% | -$6.49K | 0.04% | 383 |
|
|
2025
Q1 | $456K | Hold |
917
| – | – | 0.06% | 310 |
|
|
2024
Q4 | $477K | Sell |
917
-46
| -5% | -$23.9K | 0.06% | 291 |
|
|
2024
Q3 | $595K | Sell |
963
-28
| -3% | -$17.3K | 0.08% | 263 |
|
|
2024
Q2 | $548K | Sell |
991
-14
| -1% | -$7.74K | 0.07% | 264 |
|
|
2024
Q1 | $584K | Sell |
1,005
-177
| -15% | -$103K | 0.08% | 257 |
|
|
2023
Q4 | $627K | Hold |
1,182
| – | – | 0.1% | 225 |
|
|
2023
Q3 | $598K | Buy |
1,182
+162
| +16% | +$82K | 0.11% | 219 |
|
|
2023
Q2 | $532K | Sell |
1,020
-30
| -3% | -$15.6K | 0.09% | 246 |
|
|
2023
Q1 | $605K | Buy |
1,050
+26
| +3% | +$15K | 0.12% | 224 |
|
|
2022
Q4 | $564K | Buy |
1,024
+18
| +2% | +$9.91K | 0.12% | 233 |
|
|
2022
Q3 | $510K | Hold |
1,006
| – | – | 0.11% | 232 |
|
|
2022
Q2 | $546K | Hold |
1,006
| – | – | 0.11% | 253 |
|
|
2022
Q1 | $594K | Sell |
1,006
-38
| -4% | -$22.4K | 0.1% | 256 |
|
|
2021
Q4 | $696K | Sell |
1,044
-1
| -0.1% | -$667 | 0.11% | 218 |
|
|
2021
Q3 | $597K | Buy |
1,045
+159
| +18% | +$90.8K | 0.1% | 234 |
|
|
2021
Q2 | $447K | Sell |
886
-23
| -3% | -$11.6K | 0.08% | 297 |
|
|
2021
Q1 | $415K | Buy |
909
+23
| +3% | +$10.5K | 0.08% | 294 |
|
|
2020
Q4 | $413K | Sell |
886
-170
| -16% | -$79.2K | 0.08% | 288 |
|
|
2020
Q3 | $466K | Buy |
1,056
+157
| +17% | +$69.3K | 0.11% | 237 |
|
|
2020
Q2 | $326K | Buy |
899
+19
| +2% | +$6.89K | 0.08% | 312 |
|
|
2020
Q1 | $250K | Sell |
880
-92
| -9% | -$26.1K | 0.08% | 313 |
|
|
2019
Q4 | $316K | Buy |
972
+26
| +3% | +$8.45K | 0.07% | 335 |
|
|
2019
Q3 | $276K | Sell |
946
-396
| -30% | -$116K | 0.07% | 341 |
|
|
2019
Q2 | $394K | Buy |
1,342
+62
| +5% | +$18.2K | 0.09% | 294 |
|
|
2019
Q1 | $350K | Buy |
+1,280
| New | +$350K | 0.08% | 304 |
|
|
2017
Q3 | – | Sell |
-1,447
| Closed | -$250K | – | 380 |
|
|
2017
Q2 | $250K | Buy |
+1,447
| New | +$250K | 0.07% | 338 |
|